Skip to main content
DeutschDE
European Commission logo print header

Biochemical and functional characterization of antigen presenting cell derived-exosomes: the design of a cell free cancer vaccine

Ziel

This proposal is a combined R&D and demonstration project aimed at developing a novel therapeutic substance effective as cancer vaccine. The consortium has a unique expertise in a novel cell free vaccine i.e. the exosomes, 60-90 nm antigen presenting membrane vesicles of endosomal origin, secreted by antigen presenting cells. Characterization of exosome bioactivity will allow neosynthesis of biovectors endowed with targeting and tumor antigen transfer capacities to antigen presenting cells for active immunization. R&D objectives will be to:
1) define the biogenesis and biochemica composition of exasomes.
2) investigate their in vitra and in viva functians.
3) optimise the immunizing strategy using exosomes in preclinical tumor studies
4) design "universal" exosome based-cancer vaccine using good manufactoring procedures.

Demonstration phase involving the SME will show exosome safety and efficacy in immunizing metastatic cancer bearing patients.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

DEM - Demonstration contracts

Koordinator

INSTITUT GUSTAVE ROUSSY
EU-Beitrag
Keine Daten
Adresse


Frankreich

Auf der Karte ansehen
Links
Gesamtkosten
Keine Daten

Beteiligte (5)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 13 Juni 2006

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/QLK3-CT-2001-00093/de

European Union, 2024